BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27

• 

  Career Advice

  The top 12 companies hiring in biopharma now

  Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.

  July 2, 2026

   · 

  1 min read

   · 

  Angela Gabriel
• 

  FDA

  7 FDA decisions to watch for in Q3

  Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright rejected, including one for an mRNA vaccine that became the center of controversy earlier this year.

  July 2, 2026

   · 

  7 min read

   · 

  Tristan Manalac
• 

  Job Trends

  8 companies hiring in Greater Philadelphia

  Looking for your next role in Philly? Here are eight companies currently hiring.

  July 2, 2026

   · 

  1 min read

   · 

  Chantal Dresner
• Press Releases

  Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia

  July 2, 2026

   · 

  11 min read
• Press Releases

  Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

  July 2, 2026

   · 

  8 min read
• Press Releases

  Fosun International Garners Five Awards from Corporate Governance Asia

  July 2, 2026

   · 

  8 min read
• Press Releases

  [Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer

  July 2, 2026

   · 

  8 min read
• Press Releases

  Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

  July 2, 2026

   · 

  7 min read
• Press Releases

  Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer

  July 2, 2026

   · 

  5 min read
• Press Releases

  Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

  July 2, 2026

   · 

  9 min read